CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks ; volume:22 ; number:1 ; day:12 ; month:5 ; year:2023 ; pages:1-17 ; date:12.2023
Molecular cancer ; 22, Heft 1 (12.5.2023), 1-17, 12.2023
- Urheber
-
Hovhannisyan, Lusine
Riether, Carsten
Aebersold, Daniel M.
Medová, Michaela
Zimmer, Yitzhak
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-023-01775-1
- URN
-
urn:nbn:de:101:1-2023090808022476871738
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hovhannisyan, Lusine
- Riether, Carsten
- Aebersold, Daniel M.
- Medová, Michaela
- Zimmer, Yitzhak
- SpringerLink (Online service)
Ähnliche Objekte (12)
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
CD8+ T cell-based cancer immunotherapy
Lung cancer immunotherapy: progress, pitfalls, and promises
Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
p16INK4a as target for T cell-based cancer immunotherapy
Natural killer cell-based immunotherapy for acute myeloid leukemia
Editorial : Next generation γδ T cell-based tumor immunotherapy
Emerging Innate Immune Cells in Cancer Immunotherapy: Promises and Challenges
Social media interventions for precision public health: promises and risks
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
P14. Cell-based gene delivery leverages conventional immunotherapy for cancer
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
CD8+ T cell-based cancer immunotherapy
Lung cancer immunotherapy: progress, pitfalls, and promises
Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
p16INK4a as target for T cell-based cancer immunotherapy
Natural killer cell-based immunotherapy for acute myeloid leukemia
Editorial : Next generation γδ T cell-based tumor immunotherapy
Emerging Innate Immune Cells in Cancer Immunotherapy: Promises and Challenges
Social media interventions for precision public health: promises and risks
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
P14. Cell-based gene delivery leverages conventional immunotherapy for cancer
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
CD8+ T cell-based cancer immunotherapy
Lung cancer immunotherapy: progress, pitfalls, and promises
Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
p16INK4a as target for T cell-based cancer immunotherapy
Natural killer cell-based immunotherapy for acute myeloid leukemia
Editorial : Next generation γδ T cell-based tumor immunotherapy
Emerging Innate Immune Cells in Cancer Immunotherapy: Promises and Challenges
Social media interventions for precision public health: promises and risks
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy